www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Chinadaily.com.cn
 
Go Adv Search

China's mums key to Nestle baby milk deal

Updated: 2012-04-25 11:19

(Agencies)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

主站蜘蛛池模板: 巨大热杵在腿间进进出出视频 | 特级毛片aaaa免费观看 | 亚洲一级理论片 | free性丰满白嫩白嫩的hd | 一级特黄特色的免费大片视频 | 成人精品久久 | 午夜宅男宅女看在线观看 | 国产成人精品免费视频大全软件 | 国产一级一片免费播放i | 欧美成人亚洲国产精品 | 国产成人tv在线观看 | 精品综合 | 日韩三级在线观看 | 日韩经典欧美精品一区 | 国产1000部成人免费视频 | 亚洲精品一区二区在线观看 | 久久中文字幕久久久久 | 欧美一区在线观看视频 | 国产在线综合一区二区三区 | 欧美成人午夜毛片免费影院 | 久草在线播放视频 | 国产成人理在线观看视频 | 91精品国产欧美一区二区 | 黄色三级网站 | 国产精品久久久久久久9999 | 八戒午夜精品视频在线观看 | 久久中文亚洲国产 | 亚洲欧美性视频 | 色www亚洲| 欧美一级毛片欧美大尺度一级毛片 | 在线观看亚洲专区 | 欧美精品v日韩精品v国产精品 | 精品国产三级a | 免费看黄网 | 91亚洲精品成人一区 | 韩国毛片基地 | 国产成人免费网站在线观看 | 免费一级毛片无毒不卡 | 国产伦理久久精品久久久久 | 成人毛片免费观看视频 | 一级做a爱过程免费视频时看 |